LXEO Lexeo Therapeutics, Inc. Common Stock logo

LXEO Lexeo Therapeutics, Inc. Common Stock

Healthcare
$5.11-2.29%ClosedMarket Cap: $401.2M

As of 2026-05-25

Insider Statistics (Q2 2026)

Acquisitions

1

Dispositions

3

Buy/Sell Ratio

0.33

Net Shares

-9,644

Shares Acquired

50,000

Shares Disposed

59,644

Total Bought ($)

$0.00

Total Sold ($)

$3.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Wed May 20Townsend Richard Nolandirector, officer: Chief Executive OfficerSell3,342$5.06336,764
Wed May 20Otero Jose Manuelofficer: Chief Operating OfficerSell1,302$5.07130,088
Thu Apr 30Sepp-Lorenzino LauradirectorSell50,000$5.8150,000
Thu Apr 30Sepp-Lorenzino LauraSell0$0.000
Tue Apr 07Townsend Richard Nolandirector, officer: Chief Executive OfficerSell55,000$5.69340,106
Tue Mar 17Townsend Richard Nolandirector, officer: Chief Executive OfficerSell2,623$2.64395,106
Tue Mar 17Otero Jose Manuelofficer: Chief Operating OfficerSell5,930$2.64131,390
Fri Feb 20Townsend Richard Nolandirector, officer: Chief Executive OfficerSell10,173$6.38392,483
Fri Feb 20Otero Jose Manuelofficer: Chief Operating OfficerSell3,016$6.40125,460
Fri Feb 20Otero Jose Manuelofficer: Chief Operating OfficerSell721$9.2763,476
Tue Feb 17Bhalla Narinder Palofficer: Chief Medical OfficerSell297,000$6.31297,000
Tue Feb 17Bhalla Narinder Palofficer: Chief Medical OfficerSell49,500$0.0049,500
Fri Feb 06Townsend Richard Nolandirector, officer: Chief Executive OfficerSell646,665$7.27646,665
Fri Feb 06Townsend Richard Nolandirector, officer: Chief Executive OfficerSell161,665$0.00402,656
Fri Feb 06Otero Jose Manuelofficer: Chief Operating OfficerSell260,000$7.27260,000